Blood-brain barrier damages and intrathecal synthesis of anti-N-methyl-D-aspartate receptor NR2 antibodies in diffuse psychiatric/neuropsychological syndromes in systemic lupus erythematosus

Arthritis Research and Therapy

Volumn 16, Issue 2, 2014, Pages

  Hirohata, Shunsei ^a   Arinuma, Yoshiyuki ^a   Yanagida, Tamiko ^b   Yoshio, Taku ^c  

^a KITASATO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b TEIKYO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c JICHI MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; IMMUNOGLOBULIN G; N METHYL DEXTRO ASPARTATE RECEPTOR NR2 ANTIBODY; RECEPTOR ANTIBODY; UNCLASSIFIED DRUG; AUTOANTIBODIES; AUTOANTIGENS; NR2A NMDA RECEPTOR; RECEPTORS, N-METHYL-D-ASPARTATE; AUTOANTIBODY; INTERLEUKIN 6; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR 2 ANTIBODY;

ADULT; ANTIBODY PRODUCTION; ARTICLE; BLOOD BRAIN BARRIER; CEREBROSPINAL FLUID; CONFUSION; CONTROLLED STUDY; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE; MIDDLE AGED; NEUROPSYCHIATRIC SYSTEMIC LUPUS ERYTHEMATOSUS; PERIPHERAL NERVOUS SYSTEM; SYSTEMIC CIRCULATION; SYSTEMIC LUPUS ERYTHEMATOSUS; BLOOD-BRAIN BARRIER; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; IMMUNOLOGY; LUPUS VASCULITIS, CENTRAL NERVOUS SYSTEM; PATHOLOGY; ALBUMIN BLOOD LEVEL; ANXIETY DISORDER; BINDING AFFINITY; CEREBROVASCULAR DISEASE; COGNITIVE DEFECT; DIFFUSE NEUROPSYCHIATRIC SYSTEMIC LUPUS ERYTHEMATOSUS; MOOD DISORDER; MOTOR DYSFUNCTION; NEUROLOGIC DISEASE; POLYNEUROPATHY; PROTEIN CEREBROSPINAL FLUID LEVEL; PSYCHOSIS; SEIZURE;

ADULT; AUTOANTIBODIES; AUTOANTIGENS; BLOOD-BRAIN BARRIER; CEREBROSPINAL FLUID; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; LUPUS VASCULITIS, CENTRAL NERVOUS SYSTEM; MALE; RECEPTORS, N-METHYL-D-ASPARTATE;

EID: 84902011214     PISSN: 14786354     EISSN: 14786362     Source Type: Journal    
DOI: 10.1186/ar4518     Document Type: Article

References (34)

1. Gibson T, Myers AR. Nervous system involvement in systemic lupus erythematosus. Ann Rheum Dis 1975, 35:398-406. 1006571, 1234407.
2. Harris EN, Hughes GR. Cerebral disease in systemic lupus erythematosus. Springer Semin Immunopathol 1985, 8:251-266.
3. ACR Ad Hoc Committee on Neuropsychiatric Lupus Nomenclature The American College of Rheumatology nomenclature and case definitions for neuropsychiatric lupus syndromes. Arthritis Rheum 1999, 42:599-608. ACR Ad Hoc Committee on Neuropsychiatric Lupus Nomenclature.
4. Bertsias GK, Ioannidis JP, Aringer M, Bollen E, Bombardieri S, Bruce IN, Cervera R, Dalakas M, Doria A, Hanly JG, Huizinga TW, Isenberg D, Kallenberg C, Piette JC, Schneider M, Scolding N, Smolen J, Stara A, Tassiulas I, Tektonidou M, Tincani A, van Buchem MA, van Vollenhoven R, Ward M, Gordon C, Boumpas DT. EULAR recommendations for the management of systemic lupus erythematosus with neuropsychiatric manifestations: report of a task force of the EULAR standing committee for clinical affairs. Ann Rheum Dis 2010, 69:2074-2082. 10.1136/ard.2010.130476, 20724309.
5. Hirohata S, Miyamoto T. Elevated levels of interleukin-6 in cerebrospinal fluid from patients with systemic lupus erythematosus and central nervous system involvement. Arthritis Rheum 1990, 33:644-649. 10.1002/art.1780330506, 2346520.
6. Trysberg E, Carlsten H, Tarkowski A. Intrathecal cytokines in systemic lupus erythematosus with central nervous system involvement. Lupus 2000, 9:498-503. 10.1177/096120330000900704, 11035414.
7. Efthimiou P, Blanco M. Pathogenesis of neuropsychiatric systemic lupus erythematosus and potential biomarkers. Mod Rheumatol 2009, 19:457-468. 10.3109/s10165-009-0198-5, 19618249.
8. Fragoso-Loyo H, Richaud-Patin Y, Orozco-Narváez A, Dávila-Maldonado L, Atisha-Fregoso Y, Llorente L, Sánchez-Guerrero J. Interleukin-6 and chemokines in the neuropsychiatric manifestations of systemic lupus erythematosus. Arthritis Rheum 2007, 56:1242-1250. 10.1002/art.22451, 17393453.
9. Hirohata S, Kanai Y, Mitsuo A, Tokano Y, Hashimoto H, NPSLE Research Subcommittee Accuracy of cerebrospinal fluid IL-6 testing for diagnosis of lupus psychosis. A multicenter retrospective study. Clin Rheumatol 2009, 28:1319-1323. 10.1007/s10067-009-1226-8, 19593599, NPSLE Research Subcommittee.
10. Horai Y, Watanabe H, Miyamura T, Takahama S, Hirata A, Nakamura M, Ando H, Minami R, Yamamoto M, Suematsu E. Clinical analysis of cerebrospinal fluid interleukin-6 in neuropsychiatric systemic lupus erythematosus. Fukuoka Igaku Zasshi 2010, 101:34-40.
11. Bluestein HG, Williams GW, Steinberg AD. Cerebrospinal fluid antibodies to neuronal cells: association with neuropsychiatric manifestations of systemic lupus erythematosus. Am J Med 1981, 70:240-246. 10.1016/0002-9343(81)90756-7, 7468611.
12. Isshi K, Hirohata S. Differential roles of the anti-ribosomal P antibody and antineuronal antibody in the pathogenesis of central nervous system involvement in systemic lupus erythematosus. Arthritis Rheum 1998, 41:1819-1827. 10.1002/1529-0131(199810)41:10<1819::AID-ART14>3.0.CO;2-Y, 9778223.
13. Hirohata S, Arinuma Y, Takayama M, Yoshio T. Association of cerebrospinal fluid anti-ribosomal p protein antibodies with diffuse psychiatric/neuropsychological syndromes in systemic lupus erythematosus. Arthritis Res Ther 2007, 9:R44. 10.1186/ar2184, 2206358, 17472755.
14. Arinuma Y, Yanagida T, Hirohata S. Association of cerebrospinal fluid anti-NR2 glutamate receptor antibodies with diffuse neuropsychiatric systemic lupus erythematosus. Arthritis Rheum 2008, 58:1130-1135. 10.1002/art.23399, 18383393.
15. Yoshio T, Onda K, Nara H, Minota S. Association of IgG anti-NR2 glutamate receptor antibodies in cerebrospinal fluid with neuropsychiatric systemic lupus erythematosus. Arthritis Rheum 2006, 54:675-678. 10.1002/art.21547, 16447246.
16. Fragoso-Loyo H, Cabiedes J, Orozco-Narváez A, Dávila-Maldonado L, Atisha-Fregoso Y, Diamond B, Llorente L, Sánchez-Guerrero J. Serum and cerebrospinal fluid autoantibodies in patients with neuropsychiatric lupus erythematosus. Implications for diagnosis and pathogenesis. PLoS One 2008, 3:e3347. 10.1371/journal.pone.0003347, 2556096, 18836530.
17. Tibbling G, Link H, Ohman S. Principles of albumin and IgG analyses in neurological disorders. I. Establishment of reference values. Scand J Clin Lab Invest 1977, 37:385-390. 10.3109/00365517709091496, 337459.
18. Winfield JB, Shaw M, Silverman LM, Eisenberg RA, Wilson HA, Koffler D. Intrathecal IgG synthesis and blood-brain barrier impairment in patients with systemic lupus erythematosus and central nervous system dysfunction. Am J Med 1983, 74:837-844. 10.1016/0002-9343(83)91075-6, 6837607.
19. Reiber H, Peter JB. Cerebrospinal fluid analysis: disease-related data patterns and evaluation programs. J Neurol Sci 2001, 184:101-122. 10.1016/S0022-510X(00)00501-3, 11239944.
20. Hirohata S, Hirose S, Miyamoto T. Cerebrospinal fluid IgM, IgA, and IgG indexes in systemic lupus erythematosus. Their use as estimates of central nervous system disease activity. Arch Intern Med 1985, 145:1843-1846. 10.1001/archinte.1985.00360100105017, 3899036.
21. Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF, Schaller JG, Talal N, Winchester RJ. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982, 25:1271-1277. 10.1002/art.1780251101, 7138600.
22. DeGiorgio LA, Konstantinov KN, Lee SC, Hardin JA, Volpe BT, Diamond B. A subset of lupus anti-DNA antibodies cross-reacts with the NR2 glutamate receptor in systemic lupus erythematosus. Nat Med 2001, 7:1189-1193. 10.1038/nm1101-1189, 11689882.
23. Furukawa H, Singh SK, Mancusso R, Gouaux E. Subunit arrangement and function in NMDA receptors. Nature 2005, 438:185-192. 10.1038/nature04089, 16281028.
24. Scatton B. The NMDA receptor complex. Fundam Clin Pharmacol 1993, 7:389-400. 10.1111/j.1472-8206.1993.tb01036.x, 8294079.
25. Kowal C, DeGiorgio LA, Nakaoka T, Hetherington H, Huerta PT, Diamond B, Volpe BT. Cognition and immunity; antibody impairs memory. Immunity 2004, 21:179-188. 10.1016/j.immuni.2004.07.011, 15308099.
26. Faust TW, Chang EH, Kowal C, Berlin R, Gazaryan IG, Bertini E, Zhang J, Sanchez-Guerrero J, Fragoso-Loyo HE, Volpe BT, Diamond B, Huerta PT. Neurotoxic lupus autoantibodies alter brain function through two distinct mechanisms. Proc Natl Acad Sci USA 2010, 107:18569-18574. 10.1073/pnas.1006980107, 2972998, 20921396.
27. Yoshio T, Okamoto H, Hirohata S, Minota S. IgG anti-NR2 glutamate receptor autoantibodies from patients with systemic lupus erythematosus activate endothelial cells. Arthritis Rheum 2013, 65:457-463. 10.1002/art.37745, 23055186.
28. Hirohata S, Hayakawa K. Enhanced interleukin-6 messenger RNA expression by neuronal cells in a patient with neuropsychiatric systemic lupus erythematosus. Arthritis Rheum 1999, 42:2729-2730. 10.1002/1529-0131(199912)42:12<2729::AID-ANR35>3.0.CO;2-I, 10616027.
29. Nagai T, Arinuma Y, Yanagida T, Yamamoto K, Hirohata S. Anti-ribosomal P protein antibody in human systemic lupus erythematosus up-regulates the expression of proinflammatory cytokines by human peripheral blood monocytes. Arthritis Rheum 2005, 52:847-855. 10.1002/art.20869, 15751081.
30. Hirohata S. Anti-ribosomal P antibodies and lupus nephritis. Clin Exp Nephrol 2011, 15:471-477. 10.1007/s10157-011-0462-9, 21647580.
31. Krizanac-Bengez L, Hossain M, Fazio V, Mayberg M, Janigro D. Loss of flow induces leukocyte-mediated MMP/TIMP imbalance in dynamic in vitro blood-brain barrier model: role of pro-inflammatory cytokines. Am J Physiol Cell Physiol 2006, 291:C740-C749. 10.1152/ajpcell.00516.2005, 16707552.
32. Barichello T, Fagundes GD, Generoso JS, Paula Moreira A, Costa CS, Zanatta JR. Brain-blood barrier breakdown and pro-inflammatory mediators in neonate rats submitted meningitis by Streptococcus pneumoniae. Brain Res 2012, 1471:162-168.
33. Iwasaki T, Kanda T, Mizusawa H. Effects of pericytes and various cytokines on integrity of endothelial monolayer originated from blood-nerve barrier: an in vitro study. J Med Dent Sci 1999, 46:31-40.
34. Lee NY, Kang YS. The brain-to-blood efflux transport of taurine and changes in the blood-brain barrier transport system by tumor necrosis factor-alpha. Brain Res 2004, 1023:141-147. 10.1016/j.brainres.2004.07.033, 15364029.